Proteome Sciences Reports 13 Percent Jump in 2012 Revenues | GenomeWeb

Proteome Sciences this week reported full-year 2012 revenues of £1.2 million ($1.8 million), up 13 percent from £1 million in 2011.

The increase was driven by a jump in license, sales, and service revenue, which rose 22 percent to £810,000 from £660,000 in 2011. Grant revenue was £350,000, down 3 percent from £360,000. Revenues from sales of the company's TMT isobaric tagging reagents were up 41 percent.

Cost of sales for 2012 increased 49 percent to £385,468 from £257,274, while administrative expenses fell 2 percent to £5 million from £5.1 million.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.